WIPO Broadcasting Treaty Unfit For Needs, Might Jeopardize Access To Culture, Scholar Says 08/10/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment World Intellectual Property Organisation delegates have been negotiating a treaty aimed at protecting broadcasting organisations against signal piracy without success for the last two decades but has started to show signs of movement at the UN agency. A seminar held by a civil society group last week explored the potential implications of such a treaty on access to culture. At the event, a well-known copyright specialist argued that the current draft treaty being discussed, intended to update a 1961 treaty, does not take into consideration changes that took place since then, and in particular the transformation of broadcasting in the digital age.
US High Court To Confront Unique Copyright Issue 05/10/2018 by Steven Seidenberg for Intellectual Property Watch 1 Comment The US Supreme Court often decides momentous cases. And then there’s Fourth Estate Pub. Benefit Corp. v. Wall-Street.com. Many experts view this case as little more than a tempest in a teapot. However, the suit will resolve a legal dispute that has simmered for over 30 years, and it highlights some important copyright issues that are unique to the US.
5th Global Congress On IP And The Public Interest: Successes, Strategies Highlighted 03/10/2018 by David Branigan, Intellectual Property Watch Leave a Comment WASHINGTON, DC — More than 400 activists, academics and practitioners from over 50 countries gathered at this year’s Global Congress on Intellectual Property and the Public Interest, according to organisers. At the Congress, participants shared success stories, developed strategies, and engaged in critical dialogue to re-think and re-invent intellectual property systems that serve the public interest.
Interview With Miguel Ángel Margáin, Director General Of The Mexican Institute Of Industrial Property 01/10/2018 by William New, Intellectual Property Watch Leave a Comment Miguel Ángel Margáin, Director General of the Mexican Institute of Industrial Property, took office in early 2013, and was in Geneva for the annual World Intellectual Property Organization General Assemblies. William New of Intellectual Property Watch sat down with him for an interview. He spoke about achievements of the office during this administration, major amendments to adhere to global treaties and changes in the NAFTA, the introduction of geographical indications, and the ascendance of IP rights in Latin America.
WHO Head Highlights Tobacco Plain Packaging Victory At WTO; Vaping Lobbyists Hit Geneva 01/10/2018 by William New, Intellectual Property Watch 1 Comment World Health Organization Director General Tedros Adhanom Ghebreyesus (Dr Tedros) today hailed a dispute settlement decision at the neighbouring World Trade Organization upholding laws requiring tobacco products to be packaged without logos or designs as a way to reduce interest in smoking. Meanwhile, lobbyists for popular alternative “electronic” tobacco products such as vaping are out in force in Geneva this week.
Interview With The President Of Brazil’s Industrial Property Institute 27/09/2018 by William New, Intellectual Property Watch 1 Comment Luiz Otávio Pimentel is president of the National Institute of Industrial Property (INPI) of Brazil. In Geneva this week for the annual World Intellectual Property Organization General Assemblies he took time to sit down with Intellectual Property Watch’s William New. INPI is part of the Ministry of Industry, Foreign Trade and Services. On a breaking issue, Pimentel talked about the case in Brazil involving sofosbuvir, marketed as Sovaldi, Gilead’s effective medicine against hepatitis C that has been known for its exorbitant prices.
Interview With The Korea IP Office’s Acting Commissioner 27/09/2018 by Intellectual Property Watch Leave a Comment Korean Intellectual Property Office (KIPO) Acting Commissioner Kim Tae Man is attending the annual World Intellectual Property Organization General Assembly this week. In that context, he sat down with Intellectual Property Watch, and in a mutually prepared Q&A, he described some of KIPO’s policies and future plans, collaboration with WIPO, international partnerships, and regional efforts toward global harmonisation.
Brazil Signs Deal With Medicines Patent Pool To Share Patent Information 25/09/2018 by Catherine Saez, Intellectual Property Watch 1 Comment Brazil yesterday signed an agreement with the Medicines Patent Pool (MPP), through which the country will share patent information with the MPP. The Brazilian IP office joins several others in an effort to regular update of the MPP’s database on patent information. Separately, high-level representatives of Latin American and Iberian countries met on the side of the annual World Intellectual Property Organization General Assemblies taking place this week.
Why Follow-On Pharmaceutical Innovations Should Be Eligible For Patent Protection 21/09/2018 by Intellectual Property Watch 1 Comment Christopher M. Holman writes: Despite the important role of intellectual property rights in incentivizing innovation, the patenting of pharmaceutical innovation is frequently accused of impeding access to medicine. Criticism of the prevailing patent regime has focused in particular on patents directed towards follow-on pharmaceutical innovation, i.e., innovation that seeks to improve upon existing pharmaceuticals and their use in treating patients. Patents on follow-on innovation are often derided as “secondary” patents, with the implication that the underlying inventions are somehow lesser in nature than the subject matter claimed in “primary” patents, i.e., the drug active ingredient per se. While implicitly acknowledging the legitimacy of primary patents, critics of so-called secondary patents contend that patents on follow-on innovation allow drug innovators to “evergreen” their products, i.e., to extend the period of patent exclusivity beyond the expiration of any original patent on the drug active ingredient, and in doing so contribute to the high cost of drugs, thereby limiting the ability of patients to access the drugs upon which they have come to rely.
US, EU Consumer Group Releases Resolution Calling To Delink R&D From Monopoly Incentives 20/09/2018 by David Branigan, Intellectual Property Watch 1 Comment The Trans Atlantic Consumer Dialogue (TACD), a forum of United States and European Union consumer organisations, yesterday released a resolution calling on policymakers “to break out of the current dysfunctional and harmful trade-off between innovation and access,” and to delink research and development (R&D) from monopoly pricing.